vs
Side-by-side financial comparison of Dexcom (DXCM) and INSPERITY, INC. (NSP). Click either name above to swap in a different company.
INSPERITY, INC. is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Dexcom). On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 3.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -3.8%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Insperity, Inc., previously known as Administaff, Inc., is a professional employer organization (PEO) headquartered in Kingwood, an area of Houston, Texas, USA. Insperity provides human resources and administrative services to small and medium-sized businesses. Since 2004, the company has been title sponsor of a professional golf tournament on the Champions Tour, previously known as the Administaff Small Business Classic.
DXCM vs NSP — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $1.7B |
| Net Profit | $267.3M | — |
| Gross Margin | 62.9% | 10.3% |
| Operating Margin | 25.6% | -2.8% |
| Net Margin | 21.2% | — |
| Revenue YoY | 21.6% | 3.4% |
| Net Profit YoY | 153.6% | — |
| EPS (diluted) | $0.67 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.7B | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.0B | $1.9B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $994.2M | $1.6B | ||
| Q2 24 | $1.0B | $1.6B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $-20.0M | ||
| Q2 25 | $179.8M | $-5.0M | ||
| Q1 25 | $105.4M | $51.0M | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | $3.0M | ||
| Q2 24 | $143.5M | $18.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 10.3% | ||
| Q3 25 | 60.5% | 12.0% | ||
| Q2 25 | 59.5% | 13.4% | ||
| Q1 25 | 56.9% | 16.6% | ||
| Q4 24 | 58.9% | 13.5% | ||
| Q3 24 | 59.7% | 14.7% | ||
| Q2 24 | 62.4% | 16.2% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | -2.8% | ||
| Q3 25 | 20.1% | -1.5% | ||
| Q2 25 | 18.4% | -0.4% | ||
| Q1 25 | 12.9% | 3.7% | ||
| Q4 24 | 17.0% | -0.9% | ||
| Q3 24 | 15.3% | 0.1% | ||
| Q2 24 | 15.7% | 1.4% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | -1.2% | ||
| Q2 25 | 15.5% | -0.3% | ||
| Q1 25 | 10.2% | 2.7% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | 0.2% | ||
| Q2 24 | 14.3% | 1.1% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $-0.87 | ||
| Q3 25 | $0.70 | $-0.53 | ||
| Q2 25 | $0.45 | $-0.14 | ||
| Q1 25 | $0.27 | $1.35 | ||
| Q4 24 | $0.37 | $-0.21 | ||
| Q3 24 | $0.34 | $0.07 | ||
| Q2 24 | $0.35 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $682.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $46.0M |
| Total Assets | $6.3B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $682.0M | ||
| Q3 25 | $1.8B | $521.0M | ||
| Q2 25 | $1.2B | $511.0M | ||
| Q1 25 | $904.9M | $684.0M | ||
| Q4 24 | $606.1M | $1.2B | ||
| Q3 24 | $621.2M | $596.0M | ||
| Q2 24 | $939.2M | $850.0M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $46.0M | ||
| Q3 25 | $2.7B | $87.0M | ||
| Q2 25 | $2.6B | $112.0M | ||
| Q1 25 | $2.3B | $119.0M | ||
| Q4 24 | $2.1B | $97.0M | ||
| Q3 24 | $2.0B | $125.0M | ||
| Q2 24 | $2.4B | $142.0M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $2.2B | ||
| Q3 25 | $7.5B | $2.0B | ||
| Q2 25 | $7.3B | $2.0B | ||
| Q1 25 | $6.8B | $2.1B | ||
| Q4 24 | $6.5B | $2.6B | ||
| Q3 24 | $6.4B | $1.9B | ||
| Q2 24 | $6.8B | $2.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $255.0M |
| Free Cash FlowOCF − Capex | — | $246.0M |
| FCF MarginFCF / Revenue | — | 14.7% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-309.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $255.0M | ||
| Q3 25 | $659.9M | $-11.0M | ||
| Q2 25 | $303.0M | $-79.0M | ||
| Q1 25 | $183.8M | $-443.0M | ||
| Q4 24 | $301.4M | $619.0M | ||
| Q3 24 | $199.5M | $-150.0M | ||
| Q2 24 | $279.4M | $20.0M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $246.0M | ||
| Q3 25 | $579.4M | $-20.0M | ||
| Q2 25 | $208.9M | $-86.0M | ||
| Q1 25 | $96.8M | $-449.0M | ||
| Q4 24 | $176.8M | $606.0M | ||
| Q3 24 | $88.3M | $-164.0M | ||
| Q2 24 | $213.3M | $14.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 14.7% | ||
| Q3 25 | 47.9% | -1.2% | ||
| Q2 25 | 18.1% | -5.2% | ||
| Q1 25 | 9.3% | -24.1% | ||
| Q4 24 | 15.9% | 37.6% | ||
| Q3 24 | 8.9% | -10.5% | ||
| Q2 24 | 21.2% | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.5% | ||
| Q3 25 | 6.7% | 0.6% | ||
| Q2 25 | 8.1% | 0.4% | ||
| Q1 25 | 8.4% | 0.3% | ||
| Q4 24 | 11.2% | 0.8% | ||
| Q3 24 | 11.2% | 0.9% | ||
| Q2 24 | 6.6% | 0.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | -8.69× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | -50.00× | ||
| Q2 24 | 1.95× | 1.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
NSP
| Northeast | $455.0M | 27% |
| West | $339.0M | 20% |
| Southwest | $317.0M | 19% |
| Central | $299.0M | 18% |
| Southeast | $241.0M | 14% |
| Other Revenues | $17.0M | 1% |